Rsls earnings
WebApr 6, 2024 · Earnings Update: ReShape Lifesciences Inc. (NASDAQ:RSLS) Just Reported And Analysts Are Trimming Their Forecasts finance.yahoo.com - March 31 at 3:53 PM: ReShape Lifesciences Inc. (RSLS) uk.finance.yahoo.com - March 28 at 11:03 PM: ReShape Lifesciences GAAP EPS of $5.00, revenue of $13.69M seekingalpha.com - March 28 at … WebMar 23, 2024 · Reshape Lifesciences ( RSLS) is scheduled to report earnings on May 22, 2024. The last reported earnings were for reported on November 14, 2024 for Q3. Q What …
Rsls earnings
Did you know?
WebRSLS : 17.04 (+170.48%) ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds Globe Newswire - Fri Jun 17, 2024. SAN CLEMENTE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic... WebReShape Lifesciences Inc. analyst estimates, including RSLS earnings per share estimates and analyst recommendations.
WebApr 13, 2024 · ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) and OrthoPediatrics (NASDAQ:KIDS – Get Rating) are both small-cap medical companies, but which is the … WebApr 14, 2024 · RSLS ReShape Lifesciences Inc. Stock Price & Overview $2.59 -0.19 ( -6.68%) 3:39 PM 03/17/23 NASDAQ $USD Delayed Summary Ratings Financials Earnings …
WebApr 13, 2024 · ReShape Lifesciences (OTCMKTS:RSLS – Get Rating) and OrthoPediatrics (NASDAQ:KIDS – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations … Weba. Analysing RSLS's past stock price performance after earnings announcements. b. Evaluating demand and supply activities around RSLS's earnings. c. Studying the company's fundamentals. d. Keeping track of peer companies and the price changes that happen after earnings releases in the same quarter as RSLS’s scheduled announcements.
WebOn Nov 14, 2024, Reshape Lifesciences ( NASDAQ: RSLS) reported Q3 2024 earnings per share (EPS) of -$26.00, up 50% year over year. Total Reshape Lifesciences earnings for …
WebRSLS +500% upside potential according to this analyst RSLS, ReShape Lifesciences, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. tasheel login mohreWebRSLS will report FY 2024 earnings on 04/12/2024. Yearly Estimates. 2024 2024 2024 2024. High ... the brucebandWeb29 rows · Mar 17, 2024 · ReShape Lifesciences (OTCMKTS:RSLS) has a recorded net income of -$61.93 million. RSLS has ... the bruce effect in miceWeb1 Day RSLS 2.23% DJIA 0.01% Russell 2K 0.00% Health Care/Life Sciences 0.01% Overview Earnings & Estimates ReShape Lifesciences Inc. Per Share Data ReShape Lifesciences Inc. All values... the bruce dickinson snlWebRSLS Stock Price - ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. ... It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. ReShape Lifesciences Inc.'s EBITDA is -0.03. tasheel law firmWebNext quarter’s earnings estimate for RSLS is -$10.00 with a range of -$10.50 to -$9.50. The previous quarter’s EPS was -$29.25. RSLS beat its EPS estimate 0.00% of the time in the … tasheel near business bayWebMar 31, 2024 · earnings-and-revenue-growth Following the latest results, ReShape Lifesciences' twin analysts are now forecasting revenues of US$18.9m in 2024. This would be a huge 39% improvement in sales... the bruce craft house